Hajdu István

Division of Nuclear Medicine and Translational Imaging

2016-

Name: Hajdu István

Affiliation: Debreceni Egyetem. Általános Orvostudományi Kar. Orvosi Képalkotó Intézet. Nukleáris Medicina Nem Önálló Tanszék / University of Debrecen. Faculty of Medicine. Department of Medical Imaging. Division of Nuclear Medicine and Translational Imaging

Other profiles: Google Scholar, MTMT

Degree

PhD, Debreceni Egyetem (2014)

Profession

Profession: chemist

Media links

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2007-2024

2024

Arató, V., Képes, Z., Péli-Szabó, J., Farkasinszky, G., Sass, T., Dénes, N., Kis, A., Opposits, G., Jószai, I., Kálmán, F., Hajdu, I., Trencsényi, G., Kertész, I.: Acute Myelomonoblastic Leukemia (My1/De): a Preclinical Rat Model.
In Vivo. "Accepted by Publisher"2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2022)
Q3 Cancer Research (2022)
Q2 Medicine (miscellaneous) (2022)
Q3 Pharmacology (2022)
Képes, Z., Hegedűs, É., Sass, T., Csíkos, C., Péli-Szabó, J., Szugyiczki, V., Hajdu, I., Kertész, I., Opposits, G., Imrek, J., Balkay, L., Kálmán, F., Trencsényi, G.: Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: insight Into Tumor Hypoxia.
In Vivo. 38 (2), 574-586, 2024.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2022)
Q3 Cancer Research (2022)
Q2 Medicine (miscellaneous) (2022)
Q3 Pharmacology (2022)

2023

Képes, Z., Hajdu, I., Fenyvesi, F., Trencsényi, G.: Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era.
Int. J. Pharm. 640 1-12, 2023.

Journal metrics:

D1 Pharmaceutical Science (2022)
Péli-Szabó, J., Csige, K., Kálmán-Szabó, I., Arató, V., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Méhes, G., Fenyvesi, F., Hajdu, I., Trencsényi, G.: In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-[béta]-cyclodextrin (HPβCD) using positron emission tomography.
Int. J. Pharm. 630 1-8, 2023.

Journal metrics:

D1 Pharmaceutical Science (2022)
Képes, Z., Dénes, N., Kertész, I., Hajdu, I., Trencsényi, G.: Overview of Prostaglandin E2 (PGE2)-Targeting Radiolabelled Imaging Probes from Preclinical Perspective: Lessons Learned and Road Ahead.
Int. J. Mol. Sci. 24 (8), 1-15, 2023.

Journal metrics:

Q2 Catalysis (2022)
Q1 Computer Science Applications (2022)
D1 Inorganic Chemistry (2022)
Q1 Medicine (miscellaneous) (2022)
Q2 Molecular Biology (2022)
Q1 Organic Chemistry (2022)
Q1 Physical and Theoretical Chemistry (2022)
D1 Spectroscopy (2022)
Képes, Z., Arató, V., Péli-Szabó, J., Gyuricza, B., Szücs, D., Hajdu, I., Fekete, A., Bruchertseifer, F., Szikra, D., Trencsényi, G.: Therapeutic Performance Evaluation of 213Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([213Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: a Treasured Tailor for Oncology.
Pharmaceutics. 15 (2), 1-15, 2023.

Journal metrics:

Q1 Pharmaceutical Science (2022)

2022

Képes, Z., Barkóczi, A., Péli-Szabó, J., Kálmán-Szabó, I., Arató, V., Garai, I., Árkosy, P., Jószai, I., Deák, Á., Kertész, I., Hajdu, I., Trencsényi, G.: In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models.
Int. J. Mol. Sci. 23 (21), 1-16, 2022.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Péli-Szabó, J., Dénes, N., Arató, V., Rácz, S., Kis, A., Opposits, G., Képes, Z., Hajdu, I., Jószai, I., Emri, M., Kertész, I., Mező, G., Trencsényi, G.: In Vivo Imaging of Neo-angiogenesis of Transplanted Metastases in Subrenal Capsule Assay Induced Rat Model.
In Vivo. 36 (4), 1667-1675, 2022.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Pharmacology
Csige, K., Péli-Szabó, J., Kálmán-Szabó, I., Dénes, N., Szikra, D., Képes, Z., Opposits, G., Méhes, G., Kertész, I., Fenyvesi, F., Trencsényi, G., Hajdu, I.: In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Int. J. Pharm. 625 1-10, 2022.

Journal metrics:

D1 Pharmaceutical Science
Képes, Z., Barkóczi, A., Péli-Szabó, J., Kálmán-Szabó, I., Arató, V., Jószai, I., Deák, Á., Kertész, I., Hajdu, I., Trencsényi, G.: In Vivo Preclinical Assessment of β-Amyloid-Affine [11C]C-PIB Accumulation in Aluminium-Induced Alzheimer's Disease-Resembling Hypercholesterinaemic Rat Model.
Int. J. Mol. Sci. 23 1-14, 2022.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Kálmán-Szabó, I., Péli-Szabó, J., Arató, V., Dénes, N., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Fekete, A., Szikra, D., Hajdu, I., Trencsényi, G.: PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
Int. J. Mol. Sci. 23 (17), 1-17, 2022.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Bereczki, I., Vimberg, V., Lőrincz, E., Papp, H., Nagy, L., Kéki, S., Batta, G., Mitrović, A., Kos, J., Zsigmond, Á., Hajdu, I., Lőrincz, Z., Bajusz, D., Petri, L., Hodek, J., Jakab, F., Keserű, G., Weber, J., Neasens, L., Herczegh, P., Borbás, A.: Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.
Sci. Rep. 12 (1), 12-17, 2022.

Journal metrics:

D1 Multidisciplinary

2021

Dénes, N., Kis, A., Péli-Szabó, J., Jószai, I., Hajdu, I., Arató, V., Enyedi, K., Mező, G., Hunyadi, J., Trencsényi, G., Kertész, I.: In vivo preclinical assessment of novel 68Ga-labelled peptides for imaging of tumor associated angiogenesis using positron emission tomography imaging.
Appl. Radiat. Isot. 174 1-10, 2021.

Journal metrics:

Q3 Radiation

2020

Kis, A., Péli-Szabó, J., Dénes, N., Vágner, A., Nagy, G., Garai, I., Fekete, A., Szikra, D., Hajdu, I., Matolay, O., Méhes, G., Mező, G., Kertész, I., Trencsényi, G.: In vivo Imaging of Hypoxia and Neoangiogenesis in Experimental Syngeneic Hepatocellular Carcinoma Tumor Model Using Positron Emission Tomography.
Biomed Res. Int. 2020 1-10, 2020.

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Immunology and Microbiology (miscellaneous)
Q2 Medicine (miscellaneous)
Trencsényi, G., Kis, A., Péli-Szabó, J., Ráti, Á., Csige, K., Fenyvesi, É., Szente, L., Malanga, M., Méhes, G., Emri, M., Kertész, I., Vecsernyés, M., Fenyvesi, F., Hajdu, I.: In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography.
Int. J. Pharm. 576 1-35, 2020.

Journal metrics:

D1 Pharmaceutical Science

2019

Makhlouf, A., Hajdu, I., Hartimath, S., Alizadeh, E., Wharton, K., Wasan, K., Badea, I., Fonge, H.: 111In-Labeled Glycoprotein Nonmetastatic b (GPNMB) Targeted Gemini Surfactant-Based Nanoparticles against Melanoma: In Vitro Characterization and in Vivo Evaluation in Melanoma Mouse Xenograft Model.
Mol. Pharmaceutics. 16 (2), 542-551, 2019.

Journal metrics:

Q1 Drug Discovery
Q2 Molecular Medicine
D1 Pharmaceutical Science
Hajdu, I., Angyal, J., Szikra, D., Kertész, I., Malanga, M., Fenyvesi, É., Szente, L., Vecsernyés, M., Bácskay, I., Váradi, J., Fehér, P., Ujhelyi, Z., Vasvári, G., Rusznyák, Á., Trencsényi, G., Fenyvesi, F.: Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD).
Eur. J. Pharm. Sci. 128 202-208, 2019.

Journal metrics:

Q1 Pharmaceutical Science
Körhegyi, Z., Rózsa, D., Hajdu, I., Bodnár, M., Kertész, I., Kerekes, K., Kun, S., Kollár, J., Varga, J., Garai, I., Trencsényi, G., Borbély, J.: Synthesis of 68Ga-Labeled Biopolymer-based Nanoparticle Imaging Agents for Positron-emission Tomography.
Anticancer Res. 39 (5), 2415-2427, 2019.

Journal metrics:

Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology

2018

Hajdu, I., Makhlouf, A., Solomon, V., Michel, D., Al-Dulaymi, M., Wasan, K., Fonge, H., Badea, I.: A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior.
IJN. 13 7801-7818, 2018.

Journal metrics:

Q1 Bioengineering
Q1 Biomaterials
Q1 Biophysics
Q1 Drug Discovery
Q1 Medicine (miscellaneous)
Q2 Nanoscience and Nanotechnology
Q1 Organic Chemistry
Q1 Pharmaceutical Science
Mikolajczak, R., Pawlak, D., Wojdowska, W., Janiak, T., Barcikowski, T., Zoltowska, M., Cieszykowska, I., Parus, J., Hajdu, I., Baranyai, G., Forgács, V., Szikra, D., Nagy, G.: Cyclotron production of Sc-44 from natural calcium.
J. Nucl. Med. 59 (Suppl.), 1043, 2018.
Makhlouf, A., Hajdu, I., Badea, I.: Gemini surfactant-based systems for drug and gene delivery.
In: Organic Materials as Smart Nanocarriers for Drug Delivery. Ed.: Alexandru Mihai Grumezescu, Elsevier, Oxford, 561-600, 2018. ISBN: 9780128136638
Hajdu, I., Trencsényi, G., Fenyvesi, É., Malanga, M., Szente, L., Vasvári, G., Váradi, J., Vecsernyés, M., Fenyvesi, F.: Pharmacokinetic properties of Gallium-68 labeled hydroxypropyl-beta-cyclodextrin.
Eur. J. Nucl. Med. Mol. Imaging. 45 (S1), 1-844, 2018.

2017

Wharton, K., Hajdu, I., Makhlouf, A., Michel, D., Wasan, K., Fonge, H., Badea, I.: Development of Radiolabeled Antibody-Targeted Gemini Nanoparticles for Melanoma.
J. Pharm. Pharm. Sci. 20 133, 2017.
Hajdu, I., Forgács, V., Fekete, A., Németh, E., Szikra, D.: Development of solid target and purification for the production of scandium-44.
Nucl. Med. Rev. 20 118, 2017.
Trencsényi, G., Kis, A., Dénes, N., Péli-Szabó, J., Nagy, T., Garai, I., Szikra, D., Hajdu, I.: Effect of cholesterol rich diet on tumor growing.
Nuc. Med. Rev. 20 119, 2017.

Show all

updated: 2024-04-21, 02:09

You are here

Hajdu István

Hajdu István

Publication list

SCImago quartiles of
scientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

You are here

Hajdu István

Hajdu István

Publication list

SCImago quartiles ofscientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

SCImago quartiles of
scientific journal articles